<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药合作投融资联盟 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-16T20:46:15+08:00</updated>
  <subtitle>医药行业</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>新锐|MANA Therapeutics宣布完成3500万美元的A轮融资</title>
    <updated>2021-01-16T20:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/qKmieD3RP6FDPCp0mAEQeA</id>
    <link href="https://mp.weixin.qq.com/s/qKmieD3RP6FDPCp0mAEQeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|基因治疗LEXEO Therapeutics完成8500万美元A轮融资</title>
    <updated>2021-01-16T20:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/AQIYI4rtWadqdWfBKUAzsQ</id>
    <link href="https://mp.weixin.qq.com/s/AQIYI4rtWadqdWfBKUAzsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>B轮融资7200万美元，Werewolf将新型癌症生物疗法推向临床</title>
    <updated>2021-01-16T20:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/SzlydVxS7L6j0Hwja_tG3w</id>
    <link href="https://mp.weixin.qq.com/s/SzlydVxS7L6j0Hwja_tG3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|A轮融资6200万美元，加速taladegib治疗特发性肺纤维化临床</title>
    <updated>2021-01-16T20:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/_wbxCspXHL3Dwjb0_NYD0g</id>
    <link href="https://mp.weixin.qq.com/s/_wbxCspXHL3Dwjb0_NYD0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>A轮融资5600万美元，加速不可逆Menin抑制剂进入临床</title>
    <updated>2021-01-16T20:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/8tCRQhB29lsd3jUi3HJNqQ</id>
    <link href="https://mp.weixin.qq.com/s/8tCRQhB29lsd3jUi3HJNqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>B轮超额融资6200万美元，仅有一款MEK抑制剂处于临床前</title>
    <updated>2021-01-16T20:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/MGNPNuZJv_K6IpvAws1Baw</id>
    <link href="https://mp.weixin.qq.com/s/MGNPNuZJv_K6IpvAws1Baw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>8800万美元A轮融资，以开发针对Centyrin的基因药物</title>
    <updated>2021-01-16T20:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/D3o3kW6QIsCb8NpHq6Qz6A</id>
    <link href="https://mp.weixin.qq.com/s/D3o3kW6QIsCb8NpHq6Qz6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>B轮融资1.2亿美元，Ikena小分子产品线引起关注</title>
    <updated>2021-01-16T20:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/s3lLH2RZBxNKQpN55tQY3A</id>
    <link href="https://mp.weixin.qq.com/s/s3lLH2RZBxNKQpN55tQY3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1.96亿美元A轮融资，用于CETP抑制剂III期临床</title>
    <updated>2021-01-15T10:53:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/zAeaQITwP0E6YH9YWDmaVQ</id>
    <link href="https://mp.weixin.qq.com/s/zAeaQITwP0E6YH9YWDmaVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康方生物完成配售约12亿港元，信达生物拟再配售募资47亿港元</title>
    <updated>2021-01-15T10:53:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/5hxOpRNbLMbrqIBP2RjAUw</id>
    <link href="https://mp.weixin.qq.com/s/5hxOpRNbLMbrqIBP2RjAUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1100万美元A轮融资，加快治疗淋巴水肿和静脉疾病产品商业化</title>
    <updated>2021-01-15T10:53:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/ZZO92_AUAfPVRC3oIdVEeQ</id>
    <link href="https://mp.weixin.qq.com/s/ZZO92_AUAfPVRC3oIdVEeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|630万美元种子轮融资，加速靶向α疗法开发</title>
    <updated>2021-01-15T10:53:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/6R9c6UCs-Wjev9jxdYJlvg</id>
    <link href="https://mp.weixin.qq.com/s/6R9c6UCs-Wjev9jxdYJlvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！大数据智能医疗公司医渡云港股正式IPO，市值达574亿港元</title>
    <updated>2021-01-15T10:53:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/SRsjG2yEfhT6DzOpOwaTqg</id>
    <link href="https://mp.weixin.qq.com/s/SRsjG2yEfhT6DzOpOwaTqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>B轮融资1.55亿美元，加速IDO和PD-L1癌症疫苗临床试验</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/xfcheGEk4RFO5C0pLcMywA</id>
    <link href="https://mp.weixin.qq.com/s/xfcheGEk4RFO5C0pLcMywA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Taiho和Astex与MSD扩展肿瘤战略合作，授予SHP2新药独家许可</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/wGdlWeKwjH8GDoQe89uR8Q</id>
    <link href="https://mp.weixin.qq.com/s/wGdlWeKwjH8GDoQe89uR8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>合资新锐！一个AI驱动的药物发现企业正式成立</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/SJzIQnSQb0YvH04a-lXwww</id>
    <link href="https://mp.weixin.qq.com/s/SJzIQnSQb0YvH04a-lXwww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|Flagship正式推出Inzen公司Thanokine Biology平台开发新药</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/NE1TCFecw60husD3amOw9w</id>
    <link href="https://mp.weixin.qq.com/s/NE1TCFecw60husD3amOw9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BD交易|Amgen与EVOQ达成2.4亿美元新一代自免新药开发合作协议</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/Enhf1re8JeDHB4imqTIKgw</id>
    <link href="https://mp.weixin.qq.com/s/Enhf1re8JeDHB4imqTIKgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田宣布和KSQ达成多款T细胞和NK细胞肿瘤免疫疗法战略合作</title>
    <updated>2021-01-14T16:26:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/Ykhx-AgsDt5r-7J26MJDQg</id>
    <link href="https://mp.weixin.qq.com/s/Ykhx-AgsDt5r-7J26MJDQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>14.5亿美元收购Kymab后，赛诺菲再花超10亿美元获得一款ILT2抗体</title>
    <updated>2021-01-13T11:13:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/W2DYqoWEVPeAADCkkS6l3w</id>
    <link href="https://mp.weixin.qq.com/s/W2DYqoWEVPeAADCkkS6l3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>